These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

862 related items for PubMed ID: 17875715

  • 1. Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer.
    Buijs JT, Henriquez NV, van Overveld PG, van der Horst G, Que I, Schwaninger R, Rentsch C, Ten Dijke P, Cleton-Jansen AM, Driouch K, Lidereau R, Bachelier R, Vukicevic S, Clézardin P, Papapoulos SE, Cecchini MG, Löwik CW, van der Pluijm G.
    Cancer Res; 2007 Sep 15; 67(18):8742-51. PubMed ID: 17875715
    [Abstract] [Full Text] [Related]

  • 2. Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway.
    Katsuno Y, Hanyu A, Kanda H, Ishikawa Y, Akiyama F, Iwase T, Ogata E, Ehata S, Miyazono K, Imamura T.
    Oncogene; 2008 Oct 23; 27(49):6322-33. PubMed ID: 18663362
    [Abstract] [Full Text] [Related]

  • 3. The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells.
    Deckers M, van Dinther M, Buijs J, Que I, Löwik C, van der Pluijm G, ten Dijke P.
    Cancer Res; 2006 Feb 15; 66(4):2202-9. PubMed ID: 16489022
    [Abstract] [Full Text] [Related]

  • 4. The BMP2/7 heterodimer inhibits the human breast cancer stem cell subpopulation and bone metastases formation.
    Buijs JT, van der Horst G, van den Hoogen C, Cheung H, de Rooij B, Kroon J, Petersen M, van Overveld PG, Pelger RC, van der Pluijm G.
    Oncogene; 2012 Apr 26; 31(17):2164-74. PubMed ID: 21996751
    [Abstract] [Full Text] [Related]

  • 5. A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro.
    Yoneda T, Williams PJ, Hiraga T, Niewolna M, Nishimura R.
    J Bone Miner Res; 2001 Aug 26; 16(8):1486-95. PubMed ID: 11499871
    [Abstract] [Full Text] [Related]

  • 6. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
    Feeley BT, Gamradt SC, Hsu WK, Liu N, Krenek L, Robbins P, Huard J, Lieberman JR.
    J Bone Miner Res; 2005 Dec 26; 20(12):2189-99. PubMed ID: 16294272
    [Abstract] [Full Text] [Related]

  • 7. Bone morphogenetic protein 7 inhibits tumor growth of human uveal melanoma in vivo.
    Notting I, Buijs J, Mintardjo R, van der Horst G, Vukicevic S, Lowik C, Schalij-Delfos N, Keunen J, van der Pluijm G.
    Invest Ophthalmol Vis Sci; 2007 Nov 26; 48(11):4882-9. PubMed ID: 17962434
    [Abstract] [Full Text] [Related]

  • 8. Transforming growth factor-beta1 is the predominant isoform required for breast cancer cell outgrowth in bone.
    Mourskaia AA, Dong Z, Ng S, Banville M, Zwaagstra JC, O'Connor-McCourt MD, Siegel PM.
    Oncogene; 2009 Feb 19; 28(7):1005-15. PubMed ID: 19079339
    [Abstract] [Full Text] [Related]

  • 9. Monitoring metastatic behavior of human tumor cells in mice with species-specific polymerase chain reaction: elevated expression of angiogenesis and bone resorption stimulators by breast cancer in bone metastases.
    van der Pluijm G, Sijmons B, Vloedgraven H, Deckers M, Papapoulos S, Löwik C.
    J Bone Miner Res; 2001 Jun 19; 16(6):1077-91. PubMed ID: 11393785
    [Abstract] [Full Text] [Related]

  • 10. cAMP-response-element-binding protein positively regulates breast cancer metastasis and subsequent bone destruction.
    Son J, Lee JH, Kim HN, Ha H, Lee ZH.
    Biochem Biophys Res Commun; 2010 Jul 23; 398(2):309-14. PubMed ID: 20599715
    [Abstract] [Full Text] [Related]

  • 11. BMP7 influences proliferation, migration, and invasion of breast cancer cells.
    Alarmo EL, Pärssinen J, Ketolainen JM, Savinainen K, Karhu R, Kallioniemi A.
    Cancer Lett; 2009 Mar 08; 275(1):35-43. PubMed ID: 18980801
    [Abstract] [Full Text] [Related]

  • 12. Stimulation of cyclooxygenase-2 expression by bone-derived transforming growth factor-beta enhances bone metastases in breast cancer.
    Hiraga T, Myoui A, Choi ME, Yoshikawa H, Yoneda T.
    Cancer Res; 2006 Feb 15; 66(4):2067-73. PubMed ID: 16489006
    [Abstract] [Full Text] [Related]

  • 13. Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice.
    Sasaki A, Boyce BF, Story B, Wright KR, Chapman M, Boyce R, Mundy GR, Yoneda T.
    Cancer Res; 1995 Aug 15; 55(16):3551-7. PubMed ID: 7627963
    [Abstract] [Full Text] [Related]

  • 14. Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer.
    Hiraga T, Kizaka-Kondoh S, Hirota K, Hiraoka M, Yoneda T.
    Cancer Res; 2007 May 01; 67(9):4157-63. PubMed ID: 17483326
    [Abstract] [Full Text] [Related]

  • 15. Transcriptome profiling of a TGF-beta-induced epithelial-to-mesenchymal transition reveals extracellular clusterin as a target for therapeutic antibodies.
    Lenferink AE, Cantin C, Nantel A, Wang E, Durocher Y, Banville M, Paul-Roc B, Marcil A, Wilson MR, O'Connor-McCourt MD.
    Oncogene; 2010 Feb 11; 29(6):831-44. PubMed ID: 19935703
    [Abstract] [Full Text] [Related]

  • 16. Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions.
    Feeley BT, Krenek L, Liu N, Hsu WK, Gamradt SC, Schwarz EM, Huard J, Lieberman JR.
    Bone; 2006 Feb 11; 38(2):154-66. PubMed ID: 16126463
    [Abstract] [Full Text] [Related]

  • 17. E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model.
    Mbalaviele G, Dunstan CR, Sasaki A, Williams PJ, Mundy GR, Yoneda T.
    Cancer Res; 1996 Sep 01; 56(17):4063-70. PubMed ID: 8752180
    [Abstract] [Full Text] [Related]

  • 18. Humanized monoclonal antibody against parathyroid hormone-related protein suppresses osteolytic bone metastasis of human breast cancer cells derived from MDA-MB-231.
    Saito H, Tsunenari T, Onuma E, Sato K, Ogata E, Yamada-Okabe H.
    Anticancer Res; 2005 Sep 01; 25(6B):3817-23. PubMed ID: 16309168
    [Abstract] [Full Text] [Related]

  • 19. Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo.
    Bendre MS, Gaddy-Kurten D, Mon-Foote T, Akel NS, Skinner RA, Nicholas RW, Suva LJ.
    Cancer Res; 2002 Oct 01; 62(19):5571-9. PubMed ID: 12359770
    [Abstract] [Full Text] [Related]

  • 20. Clinical significance of BMP7 in human colorectal cancer.
    Motoyama K, Tanaka F, Kosaka Y, Mimori K, Uetake H, Inoue H, Sugihara K, Mori M.
    Ann Surg Oncol; 2008 May 01; 15(5):1530-7. PubMed ID: 18259822
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.